Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis

Documenti analoghi

• Predictors of Discontinuation of Angiotensin Converting Enzyme Inhibitors Use Among Medicare Beneficiaries Using Sodium‐Glucose Cotransporter 2 Inhibitors
  di: Hongjie Qian, et al.
  Pubblicazione: (2026)
• Disparity in Guideline‐Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017–2019
  di: Mengyuan Fu, et al.
  Pubblicazione: (2024)
• Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
  di: W. N. Kelly, et al.
  Pubblicazione: (2024)
• Longitudinal Trends in Non‐Insulin Pharmacotherapy for Type 2 Diabetes in Australian Women of Reproductive Age: Implications for Planned and Unplanned Pregnancies
  di: Farah Hashmani, et al.
  Pubblicazione: (2026)
• Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages
  di: Katie J. Suda, et al.
  Pubblicazione: (2026)